Literature DB >> 26768079

Hot topics on diabetes in China.

Jianping Weng1,2, Paolo Pozzilli3,4.   

Abstract

China is the country with the largest burden of diabetes worldwide. Action is now taking place at different levels by the Chinese Diabetes Society, which has a major role in coordinating multi-level activities across the country. These include, among others, the implementation of local guidelines for therapy, campaigns for education, trials for type 2 diabetes prevention and the establishment of extensive international collaborations in basic as well as clinical research. In this Special Issue, we briefly report on such initiatives, among which is a scientifically sound approach to exploring Chinese traditional medicine as a therapeutic option for diabetes treatment.
Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2015        PMID: 26768079     DOI: 10.1002/dmrr.2766

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  1 in total

1.  Pretreatment glycemic control status is an independent prognostic factor for cervical cancer patients receiving neoadjuvant chemotherapy for locally advanced disease.

Authors:  Jing Li; Ni-Ya Ning; Qun-Xian Rao; Rong Chen; Li-Juan Wang; Zhong-Qiu Lin
Journal:  BMC Cancer       Date:  2017-08-03       Impact factor: 4.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.